SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-35318
ZELTIQ Aesthetics, Inc.
(Exact name of registrant as specified in its charter)
4410 Rosewood Drive
Pleasanton, CA 94588
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
(Title of each class of securities covered by this Form)
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Approximate number of holders of record as of the certification or notice date: One*
|*||On April 28, 2017, pursuant to the Agreement and Plan of Merger, dated as of February 13, 2017, by and among the ZELTIQ Aesthetics, Inc., a Delaware corporation (ZELTIQ), Allergan Holdco US, Inc., a Delaware corporation (Parent), and Blizzard Merger Sub, Inc., a Delaware corporation (Merger Sub), Merger Sub merged with and into ZELTIQ, with ZELTIQ being the surviving entity (the Merger). As a result of the Merger, ZELTIQ became a wholly owned subsidiary of Parent.|
Pursuant to the requirements of the Securities Exchange Act of 1934, ZELTIQ Aesthetics, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
|ZELTIQ AESTHETICS, INC.|
|Dated: May 9, 2017|
/s/ A. Robert Bailey
|A. Robert Bailey|